↓ Skip to main content

Glucagon‐like peptide analogues for type 2 diabetes mellitus

Overview of attention for article published in Cochrane database of systematic reviews, October 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

policy
1 policy source
twitter
6 X users
wikipedia
9 Wikipedia pages

Citations

dimensions_citation
206 Dimensions

Readers on

mendeley
539 Mendeley
citeulike
2 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Glucagon‐like peptide analogues for type 2 diabetes mellitus
Published in
Cochrane database of systematic reviews, October 2011
DOI 10.1002/14651858.cd006423.pub2
Pubmed ID
Authors

Deepson S. Shyangdan, Pamela Royle, Christine Clar, Pawana Sharma, Norman Waugh, Ailsa Snaith

Abstract

Glucagon-like peptide analogues are a new class of drugs used in the treatment of type 2 diabetes that mimic the endogenous hormone glucagon-like peptide 1 (GLP-1). GLP-1 is an incretin, a gastrointestinal hormone that is released into the circulation in response to ingested nutrients. GLP-1 regulates glucose levels by stimulating glucose-dependent insulin secretion and biosynthesis, and by suppressing glucagon secretion, delayed gastric emptying and promoting satiety.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 539 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 3 <1%
Brazil 3 <1%
Germany 2 <1%
Netherlands 2 <1%
United States 2 <1%
Ireland 1 <1%
Singapore 1 <1%
France 1 <1%
Russia 1 <1%
Other 1 <1%
Unknown 522 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 74 14%
Researcher 70 13%
Student > Bachelor 64 12%
Student > Ph. D. Student 50 9%
Student > Postgraduate 45 8%
Other 106 20%
Unknown 130 24%
Readers by discipline Count As %
Medicine and Dentistry 235 44%
Nursing and Health Professions 26 5%
Pharmacology, Toxicology and Pharmaceutical Science 24 4%
Biochemistry, Genetics and Molecular Biology 22 4%
Agricultural and Biological Sciences 20 4%
Other 67 12%
Unknown 145 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 May 2023.
All research outputs
#3,430,408
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#6,035
of 11,842 outputs
Outputs of similar age
#17,809
of 144,888 outputs
Outputs of similar age from Cochrane database of systematic reviews
#52
of 130 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one is in the 45th percentile – i.e., 45% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 144,888 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 130 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.